S
Stella Hughes
Researcher at Belfast Health and Social Care Trust
Publications - 19
Citations - 408
Stella Hughes is an academic researcher from Belfast Health and Social Care Trust. The author has contributed to research in topics: Multiple sclerosis & Pregnancy. The author has an hindex of 6, co-authored 19 publications receiving 262 citations. Previous affiliations of Stella Hughes include Craigavon Area Hospital & Royal Melbourne Hospital.
Papers
More filters
Journal ArticleDOI
Predictors and dynamics of postpartum relapses in women with multiple sclerosis
Stella Hughes,Tim Spelman,Orla Gray,Cavit Boz,Maria Trojano,Alessandra Lugaresi,Guillermo Izquierdo,Pierre Duquette,Marc Girard,Francois Grand'Maison,Pierre Grammond,Celia Oreja-Guevara,Raymond Hupperts,Roberto Bergamaschi,Giorgio Giuliani,Jeannette Lechner-Scott,Michael Barnett,Maria Edite Rio,Vincent Van Pesch,Maria Pia Amato,Gerardo Iuliano,Mark Slee,Freek Verheul,Edgardo Cristiano,Ricardo Fernandez-Bolanos,Dieter Poehlau,Maria Laura Saladino,Norma Deri,Jose Antonio Cabrera-Gomez,Norbert Vella,Joseph Herbert,Eli Skromne,Aldo Savino,Cameron Shaw,Fraser Moore,Steve Vucic,Tatjana Petkovska-Boskova,Gavin McDonnell,Stanley Hawkins,Frank Kee,Helmut Butzkueven,Helmut Butzkueven,Helmut Butzkueven +42 more
TL;DR: A favourable effect on relapses as pregnancy proceeds, and an early postpartum peak, is confirmed, which could provide clinicians with a strategy to minimise post partum relapse risk in women with MS planning pregnancy.
Journal ArticleDOI
Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.
Tomas Kalincik,Ibrahima Diouf,Sifat Sharmin,Charles B Malpas,Tim Spelman,Dana Horakova,E. K. Havrdova,Maria Trojano,Guillermo Izquierdo,Alessandra Lugaresi,Alexandre Prat,Marc Girard,Pierre Duquette,P. Grammond,Vilija Jokubaitis,Anneke van der Walt,François Grand'Maison,Patrizia Sola,Diana Ferraro,Vahid Shaygannejad,Raed Alroughani,Raymond Hupperts,Murat Terzi,Cavit Boz,Jeannette Lechner-Scott,Eugenio Pucci,Vincent Van Pesch,Franco Granella,Roberto Bergamaschi,D. Spitaleri,Mark Slee,S. Vucic,Radek Ampapa,Pamela A. McCombe,Cristina Ramo-Tello,Julie Prevost,Javier Olascoaga,Edgardo Cristiano,Michael L. Barnett,Maria Laura Saladino,Jose Luis Sanchez-Menoyo,Suzanne Hodgkinson,Csilla Rozsa,Stella Hughes,Fraser Moore,Cameron Shaw,Ernest Butler,Olga Skibina,Orla Gray,Allan G. Kermode,Tünde Csépány,Bhim Singhal,Neil Shuey,Imre Piroska,Bruce V. Taylor,Magdolna Simó,Carmen Adella Sirbu,Attila Sas,Helmut Butzkueven +58 more
TL;DR: In this paper, the authors used structural models to compare the cumulative hazards of 12-month confirmed increase and decrease in disability, Expanded Disability Status Scale (EDSS) step 6, and the incidence of relapses between treated and untreated periods.
Journal ArticleDOI
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry
Stella Hughes,Tim Spelman,Maria Trojano,Alessandra Lugaresi,Guillermo Izquierdo,Francois Grand'Maison,Pierre Duquette,Marc Girard,Pierre Grammond,Celia Oreja-Guevara,Raymond Hupperts,Cavit Boz,Roberto Bergamaschi,Giorgio Giuliani,Maria Edite Rio,Jeannette Lechner-Scott,Vincent Van Pesch,Gerardo Iuliano,Marcela Fiol,Freek Verheul,Michael Barnett,Mark Slee,Joseph Herbert,Ilya Kister,Norbert Vella,Fraser Moore,Tatjana Petkovska-Boskova,Vahid Shaygannejad,Vilija Jokubaitis,Gavin McDonnell,Stanley Hawkins,Frank Kee,Orla Gray,Helmut Butzkueven +33 more
TL;DR: EDSS rank stability increases with disease duration, probably due to reduced relapses and less random variation in later disease, and is confirmed to predict 5-year outcome in individuals 4 years after disease onset.
Journal ArticleDOI
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register.
Nikos Evangelou,Afagh Garjani,Roshan dasNair,Rachael Hunter,Katherine A Tuite-Dalton,Elaine M Craig,W. J. Rodgers,Alasdair Coles,Ruth Dobson,Martin Duddy,David V. Ford,Stella Hughes,Owen R Pearson,Linda A Middleton,David Rog,Emma C. Tallantyre,Tim Friede,Rodden M. Middleton,Richard Nicholas +18 more
TL;DR: In the early phases of the UK COVID-19 outbreak, in the absence of clear evidence about the risks for people with multiple sclerosis (pwMS) and those taking immunomodulatory disease-modifying therapies (DMT), a community-based study was launched to capture the picture of CO VID-19 among pwMS and their risk of contracting the disease.
Journal ArticleDOI
Increasing age at disability milestones among MS patients in the MSBase Registry
Ilya Kister,Eric Chamot,Gary Cutter,Tamar Bacon,Vilija Jokubaitis,Stella Hughes,Orla Gray,Maria Trojano,Guillermo Izquierdo,Francois Grand'Maison,Pierre Duquette,Alessandra Lugaresi,Pierre Grammond,Cavit Boz,Raymond Hupperts,Thor Petersen,Giorgio Giuliani,Celia Oreja-Guevara,Gerardo Iuliano,Jeannette Lechner-Scott,Roberto Bergamaschi,Maria Edite Rio,Freek Verheul,Marcela Fiol,Vincent Van Pesch,Mark Slee,Helmut Butzkueven,Joseph Herbert +27 more
TL;DR: The more recent MSBase enrollees in each of the mild-to-moderate disability strata were significantly older than earlier enrollees and were observed in Poser-diagnosed as well as McDonald- diagnosed patient subsets.